CARR vs CPHI · P/E 43, rev $5.15B vs rev $4.1M
Carrier Global Corp (CARR) versus China Pharma Holdings Inc (CPHI) — a side-by-side from cached financials, not a winner call.
Carrier Global Corp (CARR) is a building products & equipment company listed on US.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CARR revenue for 2024-12-31 was $5.15B. Net income was $5.71B. Revenue was down 14.0% from 2024-09-30 to 2024-12-31. CARR currently screens at market cap $53.05B and trailing P/E 42.6.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
CARR currently screens at market cap $53.05B and trailing P/E 42.6. CPHI currently screens at market cap $29.0M.
Not investment advice. Open the CARR and CPHI stock pages for the full models.
Not investment advice.